Study shows docetaxel combined with gemcitabine is active in metastatic breast cancer

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2001年 / 15卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1517 / 1517
页数：1
相关论文
共 50 条
  • [31] Updates on gemcitabine on metastatic breast cancer
    Gligorov, Joseph
    Selle, Frderic
    Khalil, Ahmed
    Abbas, Faddi
    Namer, Moyse
    Lotz, Jean-Pierre
    BULLETIN DU CANCER, 2007, 94 : S90 - S94
  • [32] Gemcitabine and taxanes in metastatic breast cancer
    Amadori, D.
    Cecconetto, L.
    ANNALS OF ONCOLOGY, 2006, 17 : V173 - V176
  • [33] Gemcitabine and trastuzumab in metastatic breast cancer
    O'Shaughnessy, J
    SEMINARS IN ONCOLOGY, 2003, 30 (02) : 22 - 26
  • [34] Gemcitabine and cisplatin in metastatic breast cancer
    Moura, G. L.
    Pasquini, R.
    Frare, A.
    Vianna, K.
    Albini, L.
    Padilha, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] Gemcitabine for the treatment of metastatic breast cancer
    Jones, J.
    Takeda, A.
    Tan, S. C.
    Cooper, K.
    Loveman, E.
    Clegg, A.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 1 - 7
  • [36] Study of tesmilifene plus docetaxel in metastatic breast cancer launched
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (09): : 1110 - +
  • [37] Phase II study of gemcitabine in patients with metastatic breast cancer
    Blackstein, M
    Vogel, CL
    Ambinder, R
    Cowan, J
    Pearce, P
    Iglesias, J
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 664 - 664
  • [38] A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
    Clinton Yam
    Rashmi K. Murthy
    Vicente Valero
    Janio Szklaruk
    Girish S. Shroff
    Carol J. Stalzer
    Aman U. Buzdar
    James L. Murray
    Wei Yang
    Gabriel N. Hortobagyi
    Stacy L. Moulder
    Banu Arun
    Investigational New Drugs, 2018, 36 : 299 - 306
  • [39] A phase II study of tipifarnib and gemcitabine in metastatic breast cancer
    Yam, Clinton
    Murthy, Rashmi K.
    Valero, Vicente
    Szklaruk, Janio
    Shroff, Girish S.
    Stalzer, Carol J.
    Buzdar, Aman U.
    Murray, James L.
    Yang, Wei
    Hortobagyi, Gabriel N.
    Moulder, Stacy L.
    Arun, Banu
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (02) : 299 - 306
  • [40] Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study
    Stathopoulos, GP
    Tsavdaridis, D
    Malamos, NA
    Rigatos, SK
    Kosmas, C
    Pergantas, N
    Stathopoulos, JG
    Xynotroulas, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (05) : 487 - 491
12345